Business
Press Release Jul 01 2024
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 01, 2024, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Bosutinib Tablets, 100 mg and 500 mg.".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 01, 2024, titled \"Alembic Pharmaceuticals receives USFDA Tentative Approval for Bosutinib Tablets, 100 mg and 500 mg.\". View Attachment","length":389,"tagName":"div"}]